Olivia Goldhill
Olivia Goldhill

Psychedelics are suddenly drawing interest from big drugmakers

Big pharmaceutical companies are getting more comfortable with psychedelic drugs, despite the FDA’s rejection of MDMA last year.

Sep 11 25September 11, 2025

Article at STAT News

Is it ‘inevitable’ that men die more than five years earlier than women?

Men die five years earlier than women, a gap that's only grown in the last few decades. Why aren't we doing more to fix it?

Sep 09 25September 09, 2025

Article at STAT News

Insecure about their looks, more men than ever are getting plastic surgery

Insecure about their looks, more men than ever are getting plastic surgery.

Aug 12 25August 12, 2025

Article at STAT News

An overlooked demographic has the highest suicide risk — and it’s been rising

The people most at risk from suicide aren’t adolescents in angst or those experiencing a midlife lull, but men age 75 and older.

Jul 17 25July 17, 2025

Article at STAT News

Compass psilocybin therapy shown to be effective in largest-ever study in depression

Compass Pathways said Monday it achieved its primary endpoint in an early readout from the largest-ever study of psilocybin for treatment-resistant depression.

Jun 23 25June 23, 2025

Article at STAT News

Psychedelics proponents hope Trump administration will foster a new era

HHS secretary Robert F. Kennedy Jr. declared that the FDA’s “suppression of psychedelics” was about to end. Now he and his allies may be in position to do something about it.

Jun 18 25June 18, 2025

Article at STAT News

FDA rejects MDMA as a psychedelic treatment for PTSD

he Food and Drug Administration rejected MDMA as a treatment for post-traumatic stress disorder on Friday, in a blow to drug activists and veterans who’ve long campaigned for the psychedelic treatment. Although two Phase 3 trials suggested the…

Aug 09 24August 09, 2024

Article at STAT News

MDMA therapy is facing an imminent FDA decision. Here’s what you need to know

decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax as soon as Friday, with the Food and Drug Administration poised to decide whether the psychedelic should be approved as a treatment for post-traumatic stress…

Aug 09 24August 09, 2024

Article at STAT News

Trump keeps losing his train of thought. Cognitive experts have theories about why

n a speech earlier this year, former President Trump was mocking President Biden’s ability to walk through sand when he suddenly switched to talking about the old Hollywood icon Cary Grant. “Somebody said he [Biden] looks great in a bathing suit,…

Aug 07 24August 07, 2024

Article at STAT News

FDA investigators have not spoken with patients and others alleging misconduct in MDMA trials

t a contentious advisory committee meeting in June, the Food and Drug Administration announced it was investigating allegations of data suppression and misconduct in clinical trials of MDMA-assisted therapy. The agency was “quite concerned” by claims…

Jul 19 24July 19, 2024

Article at STAT News

Don’t write off MDMA yet: How the FDA got on board with psychedelics

ays after an advisory committee resoundingly voted for the Food and Drug Administration to reject MDMA as medical treatment, the founder of the company that applied for approval was ebullient. Rick Doblin, who has spent decades driving forward MDMA…

Jun 28 24June 28, 2024

Article at STAT News

The inside story of how Lykos’ MDMA research went awry

t a heated advisory committee meeting convened by the Food and Drug Administration last week, regulators repeatedly expressed frustration that Lykos, a company seeking approval of MDMA-assisted therapy to treat PTSD, failed to follow instructions and…

Jun 09 24June 09, 2024

Article at STAT News

Tracking the FDA advisory panel on MDMA therapy for PTSD

ood morning, and welcome to STAT’s live blog of the Food and Drug Administration’s scientific advisory committee meeting to review safety and efficacy data for MDMA-assisted psychotherapy to treat post-traumatic stress disorder. The discussion will…

Jun 04 24June 04, 2024

Article at STAT News

What to watch for in the crucial FDA meeting on MDMA therapy for PTSD

n less than three months, the Food and Drug Administration will decide whether to approve MDMA as the first new treatment for post-traumatic stress disorder in more than two decades. It’s a landmark moment for advocates of using psychedelics as…

May 31 24May 31, 2024

Article at STAT News

After MDMA therapy, she considered suicide. The trial data tell a different story

he MDMA study was her last hope. She had read headlines celebrating a 83% response rate in one small, early study of the psychedelic for treating PTSD, and was counting on the new clinical trial to alleviate her own post-traumatic stress disorder.…

May 24 24May 24, 2024

Article at STAT News

Hospitals largely keep quiet on maternal care since Dobbs, STAT survey finds

he Supreme Court decision to overturn Roe v. Wade has transformed not just abortion access but maternal health care across the United States, causing physicians in states with restrictive laws to shift treatment of conditions including ectopic…

Apr 22 24April 22, 2024

Article at STAT News

Florida accounts for 8% of U.S. abortions. With a forthcoming ban, where will patients go?

bortion access organizations say they are confronting an imminent crisis with Florida’s forthcoming six-week ban on abortion. The state, whose neighboring states also have imposed abortion restrictions, was home to more than 84,000 abortions last…

Apr 03 24April 03, 2024

Article at STAT News

Abortion law emergency-exemption guidance proposed by Texas Medical Board

he Texas Medical Board, responding to pressure from the state Supreme Court and widespread uncertainty among physicians, proposed draft guidance Friday in an attempt to clarify what constitutes emergency grounds for a legal abortion. A summary of the…

Mar 22 24March 22, 2024

Article at STAT News

Fetal tissue research gains in importance as roadblocks multiply

cientists at the University of Wisconsin-Madison have spent years trying to unravel the details of Down syndrome: What happens inside the womb, how the genetic disorder alters the formation of neurons, and what specific processes affect brain…

Mar 20 24March 20, 2024

Article at STAT News

FDA protocols originally intended to be extra conservative are now heralded as evidence of mifepristone’s risk

ecisions made by the Food and Drug Administration more than 20 years ago have come under heightened scrutiny thanks to a lawsuit calling for increased restrictions around the pregnancy-terminating drug mifepristone. The Alliance of Hippocratic…

Feb 27 24February 27, 2024

Article at STAT News

Built with Authory.
Get your own portfolio now!

About
Imprint
Privacy Policy
Terms